One America News (OAN) Interviews Biotricity’s CEO for his Insight into Telemedicine and how Remote Diagnostics can take it Further

CEO discusses how Biotricity’s technology fits into Telemedicine and helps Expand its Use Cases

REDWOOD CITY, Calif., April 23, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced that its CEO, Waqaas Al-Siddiq, was recently interviewed on OAN to discuss Telemedicine and how Biotricity and its Bioflux solution can be used to expand the use cases for Telemedicine.

“It is a privilege to see our technology being used to expand the scope and ability of Telemedicine during these times. Remote Diagnostics, Remote Patient Monitoring and Telemedicine are complementary technologies that together amplify their positive impact in healthcare. Recent events have put a spotlight on the individual benefits of these technologies, but their combination creates a game changing solution for care delivery. As always, no solution is perfect, but these technologies will become more and more common in the coming years,” said Dr. Al-Siddiq.

Remote Diagnostics, Remote Monitoring and Telehealth are technologies that are driving an improvement in care delivery while reducing costs. Recent events have put them front and center, accelerating the use of these technologies. In the coming months and years, we will see an increase in the adoption of these technologies as the focus continues towards reducing costs and improving care.

To watch the interview please visit:

OAN: https://www.youtube.com/watch?v=gciqoYrfApc

To learn more, join our newsletter at: https://www.biotricity.com/contact-us/ or follow on:

Twitter: @biotricity_inc Facebook: facebook.com/biotricity/ or
LinkedIn: linkedin.com/company/biotricity-measuring-vitals

About Biotricity Inc.
Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity’s R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system. To learn more, visit www.biotricity.com.